Evaxion Biotech A/S announced that it has strengthened its management team with Jesper Nyegaard Nissen as its Chief Operating Officer. Jesper Nyegaard Nissen has more than 25 years of experience in the pharmaceutical industry across finance, investments as well as research and development. He joins Evaxion from Fujifilm Diosynth Biotechnologies, where he has been on the program management team for large-scale capital projects since January 2021.